- Y Diweddaraf sydd Ar Gael (Diwygiedig)
- Pwynt Penodol mewn Amser (31/08/2006)
- Gwreiddiol (a wnaed Fel)
Version Superseded: 01/04/2007
Point in time view as at 31/08/2006. This version of this provision has been superseded.
You are viewing this legislation item as it stood at a particular point in time. A later version of this or provision, including subsequent changes and effects, supersedes this version.
Note the term provision is used to describe a definable element in a piece of legislation that has legislative effect – such as a Part, Chapter or section.
There are currently no known outstanding effects for the The Blood Safety and Quality Regulations 2005, Section 22.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
22.—(1) Blood establishments shall pay to the Secretary of State such fees as are payable in accordance with paragraphs (2) and (3).
(2) The fees payable pursuant to paragraph (1) by blood establishments in relation to authorisation under regulation 3 are—
(a)in respect of an application for authorisation pursuant to regulation 3, the sum of £2,444;
(b)in respect of an application for approval of a substantial change pursuant to regulation 4(10), the sum of £400; and
[F1(bb)in respect of the assessment by the Secretary of State of serious adverse events and serious adverse reactions notified by blood establishments, an annual haemovigilance fee calculated in accordance with paragraph (2A); and]
(c)in connection with the holding of an authorisation under regulation 3, an annual fee of the sum of £304.
[F2(2A) The fee payable under paragraph (2)(bb) shall be—
(a)in respect of the reporting year ending on 31st March 2006, £156; and
(b)in respect of each subsequent reporting year, £375.]
(3) Where the Secretary of State carries out an inspection at a site of a blood establishment he may charge the establishment and that establishment shall, if so charged, pay to the Secretary of State a fee calculated in accordance with the following sub-paragraphs—
(a)for a regular inspection of a major site, the sum of £8,729;
(b)for a regular inspection of a standard site, the sum of £5,557;
(c)for a regular inspection of a minor site, the sum of £2,698;
(d)for any other inspection, where the inspector spends at least two hours but no more than one day at the site, £1,518;
(e)for any other where an inspector spends more than one day but less than three days at the inspection site, £4,048; or
(f)for any other inspection where the inspector spends three days or more at the site, £7,590.
[F3(3A) In respect of each reporting year in which a hospital blood bank has operated, the person who is responsible for management of that hospital blood bank shall pay to the Secretary of State a fee of £400.
(3B) Subject to [F4paragraphs (3D) and (3E)], in respect of the assessment by the Secretary of State of serious adverse events and serious adverse reactions notified by hospital blood banks [F5or facilities], the person who is responsible for management of a hospital blood bank [F6or facility] shall pay to the Secretary of State an annual haemovigilance fee calculated in accordance with paragraph (3C).
(3C) The fee payable under paragraph (3C) shall be—
(b)in respect of the reporting year ending on 31st March 2006, £156; and
(c)in any other case, £375.
(3D) No fee shall be payable under paragraph (3B) by a person responsible for the management of a hospital blood bank if that person is authorised as a blood establishment under these Regulations.]
[F7(3E) No fee shall be payable under paragraph (3B) by a person responsible for the management of a facility where the facility makes arrangements with a hospital blood bank, pursuant to regulation 12B(5) that the hospital blood bank will report serious adverse reactions and events to the Secretary of State on behalf of the facility.]
(4) Where the Secretary of State carries out an inspection of a hospital blood bank [F8or a facility] he may charge the person responsible for management of the hospital blood bank [F9or the facility] and that person shall, if so charged, pay to the Secretary of State a fee calculated in accordance with paragraph (5).
(5) The fees payable by hospital blood banks [F10or facilities] in respect of inspections are—
(a)where an inspector spends at least two hours but no more than one day at the inspection site, £759;
(b)where an inspector spends more than one day but less than three days at the inspection site, £2024; or
(c)where the inspector spends three days or more at the inspection site, £3795.
[F11(5A) Where the Secretary of State carries out an inspection of a contract laboratory, he may charge the person having control of that laboratory and that person shall, if so charged, pay to the Secretary of State a fee calculated in accordance with paragraph (5B).
(5B) Subject to paragraph (5C), the fee payable under paragraph (5A) shall be—
(a)if the laboratory carries out only one type of analytical work, £2,000;
(b)if the laboratory carries out two types of analytical work, £3,000; and
(c)if the laboratory carries out three types of analytical work, £4,000.
(5C) Where an inspection referred to in paragraph (5A) takes place at the same time as an inspection by a person appointed by the Good Laboratory Practice Monitoring Authority under regulation 3(4) of the Good Laboratory Practice Regulations 1999, for the purposes of ascertaining whether the contract laboratory complies with the principles of good laboratory practice, the fee payable under paragraph (5A) shall be—
(a)if the laboratory carries out only one type of analytical work, £500;
(b)if the laboratory carries out two types of analytical work, £1,250; and
(c)if the laboratory carries out three types of analytical work, £2,000.
(5D) The types of analytical work referred to in paragraphs (5B) and (5C) are—
(a)physico-chemical analysis,
(b)microbiological analysis including sterility testing, and
(c)biological analysis.]
(6) In this regulation—
[F12“contract laboratory” means a laboratory carrying out testing of blood or blood components on behalf of, and pursuant to a contractual arrangement with—
a blood establishment which is authorised under these Regulations; or
a person responsible for management of a hospital blood bank;]
“major site” means a site at which 60 or more persons are involved in processing and quality assurance of blood or blood components;
“minor site” means a site at which fewer than 10 persons are involved in processing and quality assurance of blood or blood components;
“regular inspection” means an inspection of blood establishment pursuant to regulation 15(1);
“standard site” means a site at which at least 10 but fewer than 60 people are involved in processing and quality assurance of blood or blood components.
(7) [F13Subject to paragraph (7A),] any fee payable under this regulation shall be payable at the following times—
(i)the fee payable pursuant to paragraph (2)(a) in respect of an application for authorisation to operate a blood establishment, and the fee payable pursuant to paragraph (2)(b) in respect of an application to make a substantial change, shall, in each case, be payable at the time the application is made;
(ii)the periodic fee payable pursuant to paragraph (2)(c) shall be payable on the first anniversary of the grant by the Secretary of State of authorisation to operate as a blood establishment, and whilst the blood establishment continues to be authorised to operate as such pursuant to these Regulations, annually thereafter;
[F14(iia)any fee payable pursuant to paragraph (2)(bb) or (3B) shall be payable—
(aa)if it is payable in respect of the reporting year ending on 31st March 2006, on 31st December 2005, and
(bb)if it is payable in respect of any subsequent reporting year, on 30th April during that year;
(iib)the fee payable pursuant to paragraph (3A) shall be payable—
(aa)if it is payable in respect of the reporting year ending on 31st March 2006, on 31st December 2005, and
(bb)if it is payable in respect of any subsequent reporting year, on 30th April following the end of that year;]
(iii)any other fee payable under this regulation shall be payable within fourteen days following written notice from the Secretary of State requiring payment of the fee.
[F15(7A) In the case of a blood establishment granted an authorisation under regulation 4 before 8th November 2005, the periodic fee payable pursuant to paragraph (2)(c) shall be payable on 8th November 2006 and, while the blood establishment continues to be authorised to operate as such pursuant to these Regulations, annually thereafter.]
(8) All unpaid sums due by way of, or on account of, any fees payable under this regulation shall be recoverable as debts due to the Crown.
(9) The Secretary of State may in exceptional circumstances where it appears to him to be in the interests of safety or otherwise appropriate to do so—
(a)waive any fee or reduce any fee or part of a fee otherwise payable under this regulation; or
(b)refund the whole or part of any fee paid pursuant to this regulation.
Textual Amendments
F1Reg. 22(2)(bb) inserted (8.11.2005) by The Blood Safety and Quality (Amendment) (No. 2) Regulations 2005 (S.I. 2005/2898), regs. 1(1), 6(2)
F2Reg. 22(2A) inserted (8.11.2005) by The Blood Safety and Quality (Amendment) (No. 2) Regulations 2005 (S.I. 2005/2898), regs. 1(1), 6(3)
F3Reg. 22(3A)-(3D) inserted (8.11.2005) by The Blood Safety and Quality (Amendment) (No. 2) Regulations 2005 (S.I. 2005/2898), regs. 1(1), 6(4)
F4Words in reg. 22(3B) substituted (31.8.2006) by The Blood Safety and Quality (Amendment) Regulations 2006 (S.I. 2006/2013), regs. 1(1), 14(a)(i)
F5Words in reg. 22(3B) inserted (31.8.2006) by The Blood Safety and Quality (Amendment) Regulations 2006 (S.I. 2006/2013), regs. 1(1), 14(a)(ii)
F6Words in reg. 22(3B) inserted (31.8.2006) by The Blood Safety and Quality (Amendment) Regulations 2006 (S.I. 2006/2013), regs. 1(1), 14(a)(iii)
F7Reg. 22(3E) inserted (31.8.2006) by The Blood Safety and Quality (Amendment) Regulations 2006 (S.I. 2006/2013), regs. 1(1), 14(b)
F8Words in reg. 22(4) inserted (31.8.2006) by The Blood Safety and Quality (Amendment) Regulations 2006 (S.I. 2006/2013), regs. 1(1), 14(c)(i)
F9Words in reg. 22(4) inserted (31.8.2006) by The Blood Safety and Quality (Amendment) Regulations 2006 (S.I. 2006/2013), regs. 1(1), 14(c)(ii)
F10Words in reg. 22(5) inserted (31.8.2006) by The Blood Safety and Quality (Amendment) Regulations 2006 (S.I. 2006/2013), regs. 1(1), 14(d)
F11Reg. 22(5A)-(5D) inserted (8.11.2005) by The Blood Safety and Quality (Amendment) (No. 2) Regulations 2005 (S.I. 2005/2898), regs. 1(1), 6(5)
F12Words in reg. 22(6) inserted (8.11.2005) by The Blood Safety and Quality (Amendment) (No. 2) Regulations 2005 (S.I. 2005/2898), regs. 1(1), 6(6)
F13Words in reg. 22(7) inserted (8.11.2005) by The Blood Safety and Quality (Amendment) (No. 2) Regulations 2005 (S.I. 2005/2898), regs. 1(1), 6(7)(a)
F14Reg. 22(7)(iia)(iib) inserted (8.11.2005) by The Blood Safety and Quality (Amendment) (No. 2) Regulations 2005 (S.I. 2005/2898), regs. 1(1), 6(7)(b)
F15Reg. 22(7A) inserted (8.11.2005) by The Blood Safety and Quality (Amendment) (No. 2) Regulations 2005 (S.I. 2005/2898), regs. 1(1), 6(8)
Y Diweddaraf sydd Ar Gael (diwygiedig):Y fersiwn ddiweddaraf sydd ar gael o’r ddeddfwriaeth yn cynnwys newidiadau a wnaed gan ddeddfwriaeth ddilynol ac wedi eu gweithredu gan ein tîm golygyddol. Gellir gweld y newidiadau nad ydym wedi eu gweithredu i’r testun eto yn yr ardal ‘Newidiadau i Ddeddfwriaeth’.
Gwreiddiol (Fel y’i Deddfwyd neu y’i Gwnaed): Mae'r wreiddiol fersiwn y ddeddfwriaeth fel ag yr oedd pan gafodd ei deddfu neu eu gwneud. Ni wnaed unrhyw newidiadau i’r testun.
Pwynt Penodol mewn Amser: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Rhychwant ddaearyddol: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Dangos Llinell Amser Newidiadau: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Mae Memoranda Esboniadol yn nodi datganiad byr o ddiben Offeryn Statudol ac yn rhoi gwybodaeth am ei amcan polisi a goblygiadau polisi. Maent yn ceisio gwneud yr Offeryn Statudol yn hygyrch i ddarllenwyr nad oes ganddynt gymhwyster cyfreithiol, ac maent yn cyd-fynd ag unrhyw Offeryn Statudol neu Offeryn Statudol Drafft a gyflwynwyd ger bron y Senedd o Fehefin 2004 ymlaen.
Gallwch wneud defnydd o ddogfennau atodol hanfodol a gwybodaeth ar gyfer yr eitem ddeddfwriaeth o’r tab hwn. Yn ddibynnol ar yr eitem ddeddfwriaeth sydd i’w gweld, gallai hyn gynnwys:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Defnyddiwch y ddewislen hon i agor dogfennau hanfodol sy’n cyd-fynd â’r ddeddfwriaeth a gwybodaeth am yr eitem hon o ddeddfwriaeth. Gan ddibynnu ar yr eitem o ddeddfwriaeth sy’n cael ei gweld gall hyn gynnwys:
liciwch ‘Gweld Mwy’ neu ddewis ‘Rhagor o Adnoddau’ am wybodaeth ychwanegol gan gynnwys